These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 12271722)
1. [B-cell and cytotoxic lymphocyte immune response to virulent, attenuated and reassortant influenza viruses]. Rekstin AR; Naĭkhin AN; Barantseva IB; Rudenko LG Vopr Virusol; 2002; 47(4):27-32. PubMed ID: 12271722 [TBL] [Abstract][Full Text] [Related]
2. Immunogenic and isotype-specific responses to Russian and US cold-adapted influenza a vaccine donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57, and A/Ann Arbor/6/60 (H2N2) in mice. Wareing MD; Watson JM; Brooks MJ; Tannock GA J Med Virol; 2001 Sep; 65(1):171-7. PubMed ID: 11505460 [TBL] [Abstract][Full Text] [Related]
5. Pulmonary CD4+ cytokine responses in mice reveal differences in the relative immunogenicity of cold-adapted influenza A vaccine donor strains. Wareing MD; Harrison LC; Tannock GA Vaccine; 2005 Jul; 23(31):4075-81. PubMed ID: 15963362 [TBL] [Abstract][Full Text] [Related]
6. [Peculiarity of reassortment of current wild type influenza viruses with master donor viruses for live influenza vaccine]. Kiseleva IV; Bazhenova EA; Larionova NV; Fedorova EA; Dubrovina IA; Isakova-Sivak IN; Rudenko LG Vopr Virusol; 2013; 58(5):26-31. PubMed ID: 24640168 [TBL] [Abstract][Full Text] [Related]
7. [The generation and characteristics of reassortant influenza A virus with H5 hemagglutinin and other genes from the apathogenic virus H6N2]. Boravleva EIu; Lomakina NF; Kropotkina EA; Rudneva IA; Iamnikova SS; Rudenko LG; Drygin VV; Gambarian AS Vopr Virusol; 2011; 56(6):9-14. PubMed ID: 22359942 [TBL] [Abstract][Full Text] [Related]
8. Sensitization of mice with wild-type and cold-adapted influenza virus variants: immune response to two H1N1 and H3N2 viruses. Tao SJ; Mak NK; Ada GL J Virol; 1985 Feb; 53(2):645-50. PubMed ID: 3871484 [TBL] [Abstract][Full Text] [Related]
9. Development and characterization of a live attenuated influenza B virus vaccine candidate. Seo SU; Byun YH; Lee EY; Jung EJ; Jang YH; Kim HA; Ha SH; Lee KH; Seong BL Vaccine; 2008 Feb; 26(7):874-81. PubMed ID: 18207290 [TBL] [Abstract][Full Text] [Related]
10. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition. Johansson BE; Kilbourne ED Virology; 1996 Nov; 225(1):136-44. PubMed ID: 8918540 [TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of a cold-adapted attenuated live H3N2 subtype influenza virus vaccine candidate. An WQ; Yang PH; Duan YQ; Luo DY; Tang C; Jia WH; Xing L; Shi XF; Zhang YJ; Liu XF; Wang XL Chin Med J (Engl); 2009 Dec; 122(23):2880-5. PubMed ID: 20092795 [TBL] [Abstract][Full Text] [Related]
13. Influenza A viruses possessing type B hemagglutinin and neuraminidase: potential as vaccine components. Horimoto T; Iwatsuki-Horimoto K; Hatta M; Kawaoka Y Microbes Infect; 2004 May; 6(6):579-83. PubMed ID: 15158192 [TBL] [Abstract][Full Text] [Related]
14. [Genome composition analysis of the reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine]. Kiseleva IV; Voeten JT; Teley LC; Larionova NV; Dubrovina IA; Berdygulova ZhA; Bazhenova EA; van den Bosch H; Heldens JG; Rudenko LG Mol Gen Mikrobiol Virusol; 2011; (4):29-36. PubMed ID: 22312898 [TBL] [Abstract][Full Text] [Related]
15. Immunization with a DNA chimeric molecule encoding a hemagglutinin peptide and a scFv CD21-specific antibody fragment induces long-lasting IgM and CTL responses to influenza virus. Ivanovska N; Tchorbanov A; Prechl J; Maximova V; Voynova E; Vassilev TL Vaccine; 2006 Mar; 24(11):1830-7. PubMed ID: 16289708 [TBL] [Abstract][Full Text] [Related]
16. [The inoculative properties of cold-adapted reassortant A(H5N2) influenza strain during intranasal administration to mice]. Desheva IuA; Lu Kh; Rekstin AR; Kats DM; Rudenko LG; Klimov AI Vopr Virusol; 2007; 52(4):27-30. PubMed ID: 17722607 [TBL] [Abstract][Full Text] [Related]
17. Modification of cytotoxic T-cell response patterns by administration of hemagglutinin-specific monoclonal antibodies to mice infected with influenza A viruses. Greenspan N; Doherty PC Hybridoma; 1982; 1(2):149-59. PubMed ID: 6092263 [TBL] [Abstract][Full Text] [Related]
18. [The temperature sensitivity of epidemic influenza A viruses as a marker of immunogenicity of reassortant vaccinal strains]. Kiseleva IV; Grigor'eva EP; Naĭkhin AN; Ivanova VV; Larionova NV; Donina SA; Litvinova OM; Aleksandrova GI; Rudenko LG Vopr Virusol; 2003; 48(4):26-9. PubMed ID: 12945203 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and protective efficacy of a live attenuated vaccine against the 2009 pandemic A H1N1 in mice and ferrets. Yang P; Duan Y; Wang C; Xing L; Gao X; Tang C; Luo D; Zhao Z; Jia W; Peng D; Liu X; Wang X Vaccine; 2011 Jan; 29(4):698-705. PubMed ID: 21111782 [TBL] [Abstract][Full Text] [Related]
20. The immunogenicity of reassortants of the cold-adapted influenza A master strain A/Ann Arbor/6/60 is determined by both the genes for cold-adaptation and the haemagglutinin gene. Tannock GA; Romanova JR; Paul JA Arch Virol; 1995; 140(1):201-9. PubMed ID: 7646346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]